# A Prospective Study to Evaluate FDG-PET, Breast MRI, and Breast Ultrasonography in Monitoring Tumour Responses in Patients With Locally Advanced Breast Cancer (LABC) Undergoing Neoadjuvant Chemotherapy

> **NCT00788489** · — · COMPLETED · sponsor: **Ontario Clinical Oncology Group (OCOG)** · enrollment: 49 (actual)

## Conditions studied

- Locally Advanced Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00788489
- **Lead sponsor:** Ontario Clinical Oncology Group (OCOG)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2011-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00788489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00788489, "A Prospective Study to Evaluate FDG-PET, Breast MRI, and Breast Ultrasonography in Monitoring Tumour Responses in Patients With Locally Advanced Breast Cancer (LABC) Undergoing Neoadjuvant Chemotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00788489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*